Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mark Lückermann"'
Publikováno v:
Antimicrobial Agents and Chemotherapy. 62
Two phase II studies were performed with patients with uncomplicated urinary tract infections (uUTIs) and complicated urinary tract infections (cUTIs) or acute pyelonephritis (PN) to compare finafloxacin (300 mg twice a day [b.i.d.] orally for uUTI a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::607811822eac11d195ccad20b34824a2
https://doi.org/10.1128/aac.02325-17
https://doi.org/10.1128/aac.02325-17
Publikováno v:
Antimicrobial Agents and Chemotherapy. 62
Finafloxacin is a novel fluoroquinolone with increased antibacterial activity at acidic pH and reduced susceptibility to several resistance mechanisms. A phase II study revealed a good efficacy/safety profile in patients with complicated urinary trac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf4464cbbe2fc631c53bf10c7025e864
https://doi.org/10.1128/aac.02328-17
https://doi.org/10.1128/aac.02328-17